Clinuvel Pharmaceuticals (CLVLF) Q3 2024 Earnings

28AugConfirmed
Q1 2023
Q3 2023
Q1 2024
Q3 2024
0.14
0.2
0.27
0.33

Details

Expected EPS
0.29367063
Actual EPS
0.3293004
Surprise EPS
0.04
Surprise Percent
+12.13%

Description

Clinuvel Pharmaceuticals (CLVLF) has reported earnings of 0.3293004 per share for Q3 2024.

0 Comments

Share your thoughts